Construction and validation of a nomogram model for predicting response to initial radioiodine therapy in differentiated thyroid cancer patients using serum cytokines combined with serum thyroglobulin - Top-Institutions - MDSpire

Construction and validation of a nomogram model for predicting response to initial radioiodine therapy in differentiated thyroid cancer patients using serum cytokines combined with serum thyroglobulin

  • By

  • Guohua Qin

  • AiQiang Dong

  • Ning Wang

  • Xinfeng Liu

  • Yingying Zhang

  • Guoqiang Wang

  • Chenghui Lu

  • Jiao Li

  • Na Han

  • ZengHua Wang

  • Zengmei Si

  • Fengqi Li

  • Rui Wang

  • Congcong Wang

  • Xufu Wang

  • June 2, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Affiliated Hospital of Qingdao University
    Affiliated Hospital of Qingdao University

    Qingdao, Shandong

    Key Differentiators

    • Endocrinology

  • #2

    Qingdao Central Hospital, University of Health and Rehabilitation Sciences
    Qingdao Central Hospital, University of Health and Rehabilitation Sciences

    Qingdao, Shandong

    Key Differentiators

    • Endocrinology

  • #3

    United Italian Society of Endocrine Surgery
    United Italian Society of Endocrine Surgery

    Bari, Apulia

    Key Differentiators

    • Endocrinology

  • #4

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Endocrinology

  • #5

    Yueyang People's Hospital
    Yueyang People's Hospital

    Yueyang, Hunan

    Key Differentiators

    • Endocrinology

Original Source(s)

Construction and validation of a nomogram model for predicting response to initial radioiodine therapy in differentiated thyroid cancer patients using serum cytokines combined with serum thyroglobulin

  • by Guohua Qin, AiQiang Dong, Ning Wang, Xinfeng Liu, Yingying Zhang, Guoqiang Wang, Chenghui Lu, Jiao Li, Na Han, ZengHua Wang, Zengmei Si, Fengqi Li, Rui Wang, Congcong Wang, Xufu Wang

  • June 2, 2026

Related Content

Case Report: Intramedullary solitary fibrous tumor at the C7-T1 level diagnosed by STAT6 and treated with maximal safe resection

Case Report: Acral MYH10::ALK fusion superficial mesenchymal neoplasm: first proof of metastatic potential

Immunosuppressive contribution of tumour-infiltrating B cells in human intrahepatic cholangiocarcinoma and their role in chemoimmunotherapy outcome